Arius Formulations Private Limited

Arius Formulations Private Limited - pharma in Auroville Post, Tamil Nadu, India. FY 2026 financials and compliance.
CIN U33110TN2009PTC072482 Incorporated 05 August 2009 ROC Chennai HQ Auroville Post, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹19.26 Cr
▼ 12.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹3.16 Cr
Satisfied ₹80 Lakh
Company age
17 yrs
Est. 2009
Employees · EPFO
14
Latest available

About Arius Formulations Private Limited

Data last updated: 07 February 2026

Arius Formulations Private Limited is a private limited company based in Auroville Post, Tamil Nadu, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 05 August 2009, the company has been in operation for over 17 years.

Registered with ROC Chennai under CIN U33110TN2009PTC072482.

Capital: an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Nataraj and Alamelu Nataraj.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Auroville Post, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹19.26 Cr, a decline of 12% compared to the previous year.

The company has a workforce of approximately 14 employees as per the latest available data.

The company is associated with 1 brand - Arius Formulations. As per MCA filings, the company has open charges of ₹3.16 Cr and satisfied charges of ₹80 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Arius Formulations Private Limited
CIN U33110TN2009PTC072482
Registration Number 072482
Incorporation Date 05 August 2009
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    R.S. No. 141/1 Plot No. 38 & 47 Navarkulam Main Road Pattanur Auroville (Post) Tamil, Nadu, Auroville Post, Tamil Nadu, India – 605101
  • Industry
    Pharma, Drug Formulation & Development
Company report
Arius Formulations Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Arius Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Arius Formulations Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Arius Formulations Private Limited

Arius Formulations Private Limited operates one associated brand: Arius Formulations. These brands represent Arius Formulations Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Third-party manufacturer of pharmaceuticals, cosmetics, and pet care items. ariusfpl.com

Competitors & Alternatives of Arius Formulations Private Limited

Brands and companies operating in the same space as Arius Formulations Private Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.

Competitor Description Location Founded
Abzena Abzena Provider of antibody discovery, cell line development, and bio analytics services Cambridge, United Kingdom, United Kingdom 2001
Syngene Syngene Provider of contract research and manufacturing services for both small molecules and biologics Bengaluru, India, India 1993
Grand River Aseptic Manufacturing Grand River Aseptic Manufacturing Sterile parenteral CDMO services for development and manufacturing are offered. Grand Rapids, United States, United States 2010
Patheon Patheon Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry Durham, United States, United States 1974
Panacea Biotec Panacea Biotec Developer of biosimilars, vaccines and natural products Ambala, India, India 1984
Piramal Group Piramal Group Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate Mumbai, India, India 1984
Maravai Life Sciences Maravai Life Sciences Provides enabling tools and services in the life sciences research and bio-production industries San Diego, United States, United States 2014
LakePharma LakePharma Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering Belmont, United States, United States 2009
Insud Pharma Insud Pharma Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. Madrid, Spain, Spain 1977

Business Activity of Arius Formulations Private Limited

Arius Formulations Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Arius Formulations Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Arius Formulations Private Limited

Arius Formulations Private Limited is audited by D MUTHUNARAYANAN & CO for the financial year 2022. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
D MUTHUNARAYANAN & CO Locked Locked Locked
Premium access

Complete auditor history for Arius Formulations Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Arius Formulations Private Limited

Arius Formulations Private Limited is currently managed by 2 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Nataraj Managing Director 05 Aug 2009 17 Years 0 Months Current
Alamelu Nataraj Director 05 Aug 2009 17 Years 0 Months Current

Financials of Arius Formulations Private Limited FY 2025 filings available

Arius Formulations Private Limited reported revenue of ₹19.26 Cr (down 12.00% YoY) for FY 2025.

Revenue · FY 2025
₹19.26 Cr ▼ 12.00%
Premium access

Ten-year financial statements for Arius Formulations Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Arius Formulations Private Limited

Premium access

Shareholding and ownership data for Arius Formulations Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Arius Formulations Private Limited

Open charges
₹3.16 Cr
Satisfied charges
₹80 Lakh
Breakdown by lending institutions
Others₹2.00 Cr
Vijaya Bank₹1.16 Cr
Latest charge details
DateLenderAmountStatus
28 Jun 2023 Others ₹33.63 Lakh Open
03 Oct 2022 Others ₹1.66 Cr Open
20 Mar 2017 Vijaya Bank ₹70 Lakh Open
26 Apr 2013 Vijaya Bank ₹6.38 Lakh Open
05 Dec 2009 Vijaya Bank ₹40 Lakh Open

Total charge records: 7 View all charges

Employees and EPFO Compliance at Arius Formulations Private Limited

Arius Formulations Private Limited has a workforce of 14 employees as of Mar 30, 2024.

Employee count
14
Active EPFO establishments
1
Premium access

Employee and EPFO history for Arius Formulations Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Arius Formulations Private Limited

Premium access

GST registrations and filing compliance for Arius Formulations Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Arius Formulations Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Arius Formulations Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Arius Formulations Private Limited

Premium access

MSME payment history for Arius Formulations Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Arius Formulations Private Limited

Premium access

Corporate group structure for Arius Formulations Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Arius Formulations Private Limited

Premium access

MCA filings and documents for Arius Formulations Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Arius Formulations Private Limited

Activity
30 Sep 2025
Arius Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Arius Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
01 Sep 2023
A charge with Others of Rs. 166.00 Lakh registered on 03 Oct 2022 with Charge ID 100643838 was modified on 01 Sep 2023.
Charges
28 Jun 2023
A charge with Others amounted to Rs. 33.63 Lakh with Charge ID 100788477 was registered on 28 Jun 2023.
Charges
03 Oct 2022
A charge with Others amounted to Rs. 166.00 Lakh with Charge ID 100643838 was registered on 03 Oct 2022.
Charges
27 May 2022
A charge registered on 22 Mar 2017 via Charge ID 100146097 with Vijaya Bank was fully satisfied on 27 May 2022.

Frequently Asked Questions about Arius Formulations Private Limited

Arius Formulations Private Limited is an active private limited company in the pharma sector based in Auroville Post, Tamil Nadu, India. It was incorporated on 05 August 2009 (17+ years old) and is registered under CIN U33110TN2009PTC072482. The company has 14 employees.

Arius Formulations Private Limited reported revenue of ₹19.26 Cr for FY 2025 (down 12.00% YoY).

The current directors of Arius Formulations Private Limited are:

The primary industry of Arius Formulations Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Arius Formulations Private Limited can be reached at the registered office: R.S. No. 1411 Plot No. 38 & 47 Navarkulam Main Road Pattanur Auroville Post Tamil, Nadu, Auroville Post, Tamil Nadu, India – 605101.

The authorised capital is ₹40 Lakh, and the paid-up capital is ₹40 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available